S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:STAA

STAAR Surgical (STAA) Competitors

$57.70
-0.08 (-0.14%)
(As of 06/2/2023 ET)
Compare
Today's Range
$57.22
$59.19
50-Day Range
$57.78
$72.82
52-Week Range
$46.35
$112.27
Volume
781,125 shs
Average Volume
669,923 shs
Market Capitalization
$2.79 billion
P/E Ratio
90.16
Dividend Yield
N/A
Price Target
$81.18

STAA vs. EYE, WRBY, RXST, BLCO, GLPG, AZTA, PRVA, ITGR, ENOV, and IMVT

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include National Vision (EYE), Warby Parker (WRBY), RxSight (RXST), Bausch + Lomb (BLCO), Galapagos (GLPG), Azenta (AZTA), Privia Health Group (PRVA), Integer (ITGR), Enovis (ENOV), and Immunovant (IMVT). These companies are all part of the "medical" sector.

STAAR Surgical vs.

STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.

STAAR Surgical has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500.

In the previous week, National Vision had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for National Vision and 4 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 1.09 beat National Vision's score of 0.33 indicating that STAAR Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

STAAR Surgical has a net margin of 10.81% compared to National Vision's net margin of 1.48%. STAAR Surgical's return on equity of 9.85% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical 10.81% 9.85% 7.93%
National Vision 1.48% 3.99% 1.56%

STAAR Surgical currently has a consensus target price of $81.18, suggesting a potential upside of 40.70%. National Vision has a consensus target price of $30.33, suggesting a potential upside of 16.80%. Given STAAR Surgical's stronger consensus rating and higher possible upside, analysts plainly believe STAAR Surgical is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
National Vision
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

97.6% of STAAR Surgical shares are owned by institutional investors. 1.1% of STAAR Surgical shares are owned by insiders. Comparatively, 2.1% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

STAAR Surgical received 22 more outperform votes than National Vision when rated by MarketBeat users. However, 67.65% of users gave National Vision an outperform vote while only 58.64% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
275
58.64%
Underperform Votes
194
41.36%
National VisionOutperform Votes
253
67.65%
Underperform Votes
121
32.35%

National Vision has higher revenue and earnings than STAAR Surgical. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$284.39 million9.81$38.76 million$0.6490.16
National Vision$2.01 billion1.01$42.12 million$0.3770.19

Summary

STAAR Surgical beats National Vision on 12 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STAA vs. The Competition

MetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$2.79B$10.77B$4.56B$6.27B
Dividend YieldN/A0.83%2.42%6.35%
P/E Ratio90.1643.53102.1312.18
Price / Sales9.817.663,554.1188.11
Price / Cash65.0623.1290.64108.39
Price / Book8.233.715.216.95
Net Income$38.76M$199.84M$117.62M$193.37M
7 Day Performance-3.50%-0.06%1.74%2.26%
1 Month Performance-15.93%4.40%3.67%5.32%
1 Year Performance-15.61%5.61%21.96%1.45%

STAAR Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.218 of 5 stars
$25.68
-0.3%
$30.33
+18.1%
-6.3%$2.01B$2.01B69.4113,975
WRBY
Warby Parker
1.9618 of 5 stars
$11.54
-4.2%
$16.82
+45.7%
-30.7%$1.11B$598.11M-15.183,032
RXST
RxSight
1.408 of 5 stars
$25.16
-4.1%
$19.75
-21.5%
+88.5%$854.94M$49.01M-11.442,021Positive News
High Trading Volume
BLCO
Bausch + Lomb
1.2653 of 5 stars
$17.75
-1.1%
$20.58
+16.0%
+12.0%$6.22B$3.77B-59.1612,900
GLPG
Galapagos
1.0269 of 5 stars
$42.14
-1.7%
$45.37
+7.7%
-25.7%$2.78B$532.48M-15.161,338Analyst Report
AZTA
Azenta
2.5962 of 5 stars
$43.50
+1.9%
$64.20
+47.6%
-41.9%$2.83B$555.50M-69.053,100Positive News
PRVA
Privia Health Group
2.4101 of 5 stars
$24.54
+0.2%
$39.19
+59.7%
+6.1%$2.84B$1.36B223.09810Insider Selling
ITGR
Integer
1.8123 of 5 stars
$81.94
+2.0%
$88.67
+8.2%
+5.9%$2.73B$1.38B40.3610,000Positive News
ENOV
Enovis
1.6779 of 5 stars
$53.01
-0.5%
$64.88
+22.4%
-19.4%$2.89B$1.56B-55.226,800Positive News
IMVT
Immunovant
1.3264 of 5 stars
$20.83
-1.0%
$24.77
+18.9%
+403.2%$2.72BN/A-12.1868

Related Companies and Tools

This page (NASDAQ:STAA) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -